Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 16, 2016
Total Value: $404M (93.9% shares, 6.1% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES CORP | 2,640,251 | $47.66M | 11.8% | — | — | COM | 09627Y109 |
| — | CONCERT PHARMACEUTICALS INC | 2,755,318 | $37.64M | 9.3% | — | — | COM | 206022105 |
| CYTK | CYTOKINETICS INC | 4,340,729 | $30.6M | 7.6% | — | — | COM NEW | 23282W605 |
| — | FORWARD PHARMA A/S | 1,441,287 | $24.5M | 6.1% | — | — | SPONSORED ADR | 34986J105 |
| — | ONCOTHYREON INC | 18,799,368 | $23.88M | 5.9% | — | — | COM | 682324108 |
| — | CTI BIOPHARMA CORP | 44,796,940 | $23.8M | 5.9% | — | — | COM | 12648L106 |
| — | ARRAY BIOPHARMA INC | 7,850,211 | $23.16M | 5.7% | — | — | COM | 04269X105 |
| — | EXELIXIS INC | 22,822,778 | $22.72M | 5.6% | — | — | NOTE 4.250% 8/1 | 30161QAC8 |
| — | CHEMOCENTRYX INC | 8,182,052 | $20.37M | 5.0% | — | — | COM | 16383L106 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1,755,745 | $19.21M | 4.8% | — | — | COM CL A | 46333X108 |
| — | VITAE PHARMACEUTICALS INC | 2,089,014 | $13.85M | 3.4% | — | — | COM | 92847N103 |
| — | ONCOMED PHARMACEUTICALS INC | 1,339,336 | $13.54M | 3.4% | — | — | COM | 68234X102 |
| — | ARQULE INC | 7,893,324 | $12.63M | 3.1% | — | — | COM | 04269E107 |
| XENE | XENON PHARMACEUTICALS INC | 1,775,572 | $12.41M | 3.1% | — | — | COM | 98420N105 |
| — | QLT INC | 5,701,609 | $11.35M | 2.8% | — | — | COM | 746927102 |
| ESPR | ESPERION THERAPEUTICS INC NE | 606,801 | $10.26M | 2.5% | — | — | COM | 29664W105 |
| — | TOBIRA THERAPEUTICS INC | 1,253,401 | $10.25M | 2.5% | — | — | COM | 88883P101 |
| — | CELATOR PHARMACEUTICALS INC | 800,000 | $8.824M | 2.2% | — | — | COM | 15089R102 |
| CTMX | CYTOMX THERAPEUTICS INC | 606,138 | $7.819M | 1.9% | — | — | COM | 23284F105 |
| — | NIVALIS THERAPEUTICS INC | 1,546,743 | $6.45M | 1.6% | — | — | COM | 65481J109 |
| — | GTX INC DEL | 11,512,000 | $5.756M | 1.4% | — | — | COM | 40052B108 |
| — | PAIN THERAPEUTICS INC | 2,149,913 | $4.794M | 1.2% | — | — | COM | 69562K100 |
| — | SUNESIS PHARMACEUTICALS INC | 4,813,294 | $2.599M | 0.6% | — | — | COM NEW | 867328601 |
| — | LOXO ONCOLOGY INC | 74,870 | $2.047M | 0.5% | — | — | COM | 548862101 |
| — | ARRAY BIOPHARMA INC | 2,500,000 | $2.025M | 0.5% | — | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | CATALYST BIOSCIENCES INC | 970,948 | $1.631M | 0.4% | — | — | COM | 14888D109 |
| GBIM | GLOBEIMMUNE INC | 657,653 | $1.355M | 0.3% | — | — | COM | 37957B100 |
| — | MAST THERAPEUTICS INC | 3,696,961 | $1.013M | 0.3% | — | — | COM | 576314108 |
| — | CALITHERA BIOSCIENCES INC | 162,900 | $925K | 0.2% | — | — | COM | 13089P101 |
| — | BIOTA PHARMACEUTIALS INC | 350,776 | $526K | 0.1% | — | — | COM | 090694100 |
| — | IGNYTA INC | 50,000 | $339K | 0.1% | — | — | COM | 451731103 |
| — | NEPHROGENEX INC | 392,156 | $184K | 0.0% | — | — | COM | 640667101 |